HCA Healthcare, Inc.
HCA- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- SEC CIK
- 0000860730
In the last 90 days, HCA Healthcare, Inc. insiders filed 0 open-market purchases and 2 sales; 1,350 institutions reported holding it in 13F filings for Q2 2026, worth $51.2B in total; superinvestors Harris Associates (Oakmark) and Markel Group hold it.
Key figures
- Market capClose on Nov 10, 2026
- $105.4B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $16.5M in total
- 2
- 13F holdersQ2 2026, −64 vs. previous quarter
- 1,350
- 13F valueReported value at the end of Q2 2026
- $51.2B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $75.6B
- +7.1% year over year
- Net income, FY2025
- $6.78B
- +17.8% year over year
- Free cash flow, FY2025
- $7.69B
- +36.4% year over year
- Revenue, Q3 FY2026
- $19.8B
- +3.6% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 4.80M
- Shares sold short
- Change
- −105.1K
- −2.1% vs. previous
- Days to cover
- 3.31
- At average daily volume
Superinvestors holding HCA, Q2 2026
Go to the superinvestors tab2 superinvestors report holding HCA Healthcare, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Harris Associates (Oakmark)
Bill Nygren
0.1%
HCA Healthcare, Inc.'s share of the portfolio
- Shares
- 154,097
- Value
- $60.1M
Latest insider trades
See all insider tradesOpen-market purchases and sales by HCA Healthcare, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 (view filing)5:11 PM ET | Nov 4 | 2 days | Schlosser Michael JEVP and Chief Clinical Officer | SSale | −1.20K | $494.65 | −$593.6K | −45.4%1.44K after | |
| Nov 6, 2026 (view filing)5:09 PM ET | Nov 4-6 | 2 days | Foster Jon MEVP and COO | SSale | −31.7K | $500.98 | −$15.9M | −76.0%10.0K after | 8 lots |
| Feb 18, 2026 (view filing) | Feb 18 | Same day | McAlevey Michael REVP & Chief Legal & Admin Off. | SSale | −1.69K | $533.37 | −$903.5K | −16.1%8.85K after | |
| Feb 12, 2026 (view filing) | Feb 11 | 1 day | Wyatt Christopher F.SVP & Controller | SSale | −4.00K | $505.00 | −$2.02M | −8.3%44.4K after | |
| Feb 12, 2026 (view filing) | Feb 11 | 1 day | Berres JenniferSVP & Chief Human Res. Officer | SSale | −8.02K | $514.58 | −$4.13M | −40.1%12.0K after | 2 lots |
| Feb 5, 2026 (view filing) | Feb 3 | 2 days | Hazen Samuel NCEO | SSale | −42.9K | $501.04 | −$21.5M | −57.1%32.3K after | 7 lots |
| Feb 5, 2026 (view filing) | Feb 3 | 2 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −1.50K | $498.09 | −$747.1K | −4.8%30.0K after | |
| Nov 5, 2025 (view filing) | Nov 5 | Same day | McAlevey Michael REVP & Chief Legal & Admin Off. | SSale | −3.89K | $473.79 | −$1.84M | −52.7%3.49K after | |
| Sep 8, 2025 (view filing) | Sep 8 | Same day | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −3.84K | $418.84 | −$1.61M | −10.9%31.5K after | 10b5-1 |
| May 15, 2025 (view filing) | May 13 | 2 days | Foster Jon MEVP and COO | SSale | −15.7K | $369.32 | −$5.80M | −55.4%12.6K after |
Top 10 13F holders, Q2 2026
See all 1,350 holdersThe largest institutional positions in HCA Healthcare, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,003,600 | $5.07B | 0.08% | −359,666−2.7% | Reduced |
| Vanguard Capital Management LLC | 10,141,708 | $3.95B | 0.08% | −36,654−0.4% | Reduced |
| Sanders Capital, LLC | 8,828,287 | $3.44B | 3.45% | −128,858−1.4% | Reduced |
| State Street Corp | 7,469,035 | $2.91B | 0.09% | −70,515−0.9% | Reduced |
| Wellington Management Group LLP | 4,707,473 | $1.84B | 0.32% | +799,761+20.5% | Added |
| Geode Capital Management, LLC | 3,668,008 | $1.42B | 0.08% | −24,505−0.7% | Reduced |
| First Eagle Investment Management, LLC | 3,295,565 | $1.28B | 2.12% | +40,995+1.3% | Added |
| Vanguard Portfolio Management LLC | 2,712,828 | $1.06B | 0.05% | −44,951−1.6% | Reduced |
| Morgan Stanley | 2,586,771 | $1.01B | 0.05% | +291,891+12.7% | Added |
| Goldman Sachs Group Inc | 2,464,314 | $960.8M | 0.10% | +328,242+15.4% | Added |
Holders of 5% or more of HCA
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of HCA Healthcare, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Frisco Holding II | 13D/A | 33.80%70.5M shares | +2.20 ppfrom 31.60% | Feb 10, 20262 filings | Nov 6, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.25%11.7M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Politician trades
All politician trades in HCA11 members of Congress reported 33 trades in HCA Healthcare, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 26, 2026 |  Jared Moskowitz House · FL | Buy | $1K-$15K |
| Jul 26, 2026 | Jared Moskowitz House · FL | Buy | $1K-$15K |
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $1K-$15K |
| Oct 22, 2025 |  Lisa C. McClain House · MI | Sell | $1K-$15K |
| Sep 12, 2025 |  Val T. Hoyle House · OR | Buy | $1K-$15K |
House · FL · Jul 26, 2026
Buy$1K-$15K
House · FL · Jul 26, 2026
Buy$1K-$15K
Senate · OK · Jul 21, 2026
Buy$1K-$15K
House · MI · Oct 22, 2025
Sell$1K-$15K
House · OR · Sep 12, 2025
Buy$1K-$15K